30-Mar-2026
Business Wire (Mon, 16-Mar 5:57 PM ET)
PACS Group, Inc. Appoints Dr. Patrick Conway, MD, MSc to Board of Directors
Business Wire (Thu, 5-Mar 9:00 AM ET)
PACS Group, Inc. Reports Fiscal Year and Fourth Quarter 2025 Results
Business Wire (Thu, 26-Feb 4:15 PM ET)
PACS Group Intends to Release Fiscal Year and Fourth Quarter 2025 Earnings on February 26, 2026
Business Wire (Wed, 25-Feb 6:17 PM ET)
Business Wire (Tue, 20-Jan 5:41 PM ET)
Business Wire (Mon, 12-Jan 4:15 PM ET)
Market Chameleon (Thu, 20-Nov 5:29 AM ET)
Market Chameleon (Mon, 17-Nov 5:30 AM ET)
PACS Group Inc is a post-acute healthcare company mainly focused on delivering skilled nursing care through a portfolio of independently operated facilities. The post-acute care ecosystem serves individuals who need additional help recuperating from acute conditions, illnesses, or serious medical procedures after getting discharged from the hospital. It also provides senior care, assisted living, and independent living options in some of the communities. The company has one reportable segment.
Pacs Group trades on the NYSE stock market under the symbol PACS.
As of March 30, 2026, PACS stock price declined to $30.38 with 1,279,984 million shares trading.
PACS has a beta of 0.52, meaning it tends to be less sensitive to market movements. PACS has a correlation of 0.01 to the broad based SPY ETF.
PACS has a market cap of $4.76 billion. This is considered a Mid Cap stock.
Last quarter Pacs Group reported $1 billion in Revenue and $.49 earnings per share. This fell short of revenue expectation by $-12 million and exceeded earnings estimates by $.05.
The top ETF exchange traded funds that PACS belongs to (by Net Assets): VTI, VB, IWM, AVUV, VBK.
PACS has outperformed the market in the last year with a return of +178.5%, while the SPY ETF gained +15.1%. However, in the most recent history, PACS shares have underperformed the stock market with its stock returning -22.6% in the last 3 month period and -13.3% for the last 2 week period, while SPY has returned -7.7% and -5.3%, respectively.
PACS support price is $29.67 and resistance is $31.51 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PACS shares will trade within this expected range on the day.